Stock listing
PVLA Stock Price, News, Filings & Events — Palvella Therapeutics, Inc.
Selected listing: PVLA · BOATS · USD · US
This page tracks Palvella Therapeutics, Inc.'s PVLA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PVLA:BOATS. PVLA:BOATS is the stock-level entry point for investors researching Palvella Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Palvella Therapeutics, Inc. is a public company traded under the ticker PVLA in the American market. The company has a market capitalization of approximately $1.98 billion. Palvella focuses on developing innovative therapies for patients with rare diseases.
- Ticker
- PVLA:BOATS
- Asset type
- Stock
- Market cap
- $2.25B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Palvella Therapeutics, Inc. PVLA:BOATS stock context
This page tracks Palvella Therapeutics, Inc.'s PVLA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PVLA:BOATS. PVLA:BOATS is the stock-level entry point for investors researching Palvella Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Palvella Therapeutics, Inc. is a public company traded under the ticker PVLA in the American market. The company has a market capitalization of approximately $1.98 billion. Palvella focuses on developing innovative therapies for patients with rare diseases.
Latest news from Palvella Therapeutics, Inc.
Palvella Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
August 5, 2026
Palvella Therapeutics Chief Scientific Officer Jeff Martini, Ph.D. Selected to Present at Upcoming FDA Public Workshop on Drug Repurposing
July 30, 2026
Palvella Therapeutics to Host Second Quarter 2026 Financial Results and Corporate Update Conference Call on August 4, 2026
July 28, 2026
FDA Grants Rolling Review of Palvella’s QTORIN™ Rapamycin NDA for Microcystic Lymphatic Malformations
June 22, 2026
Palvella Therapeutics Announces Completion of FDA Pre-NDA Meeting for QTORIN™ Rapamycin in Microcystic Lymphatic Malformations
June 3, 2026
Palvella Therapeutics, Inc. earnings calls
Palvella Therapeutics, Inc. (PVLA) Q2 2026 Earnings Call
August 4, 2026 · Replay with transcript and chapters
Palvella Therapeutics, Inc. (PVLA) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Palvella Therapeutics, Inc. (PVLA) Q4 2025 Earnings Call
March 31, 2026 · Replay with transcript and chapters
Palvella Therapeutics, Inc. (PVLA) Q3 2025 Earnings Call
November 11, 2025 · Replay with transcript and chapters
Palvella Therapeutics, Inc. (PVLA) Q2 2025 Earnings Call
August 14, 2025 · Replay with transcript and chapters
Palvella Therapeutics, Inc. (PVLA) Q1 2025 Earnings Call
May 15, 2025 · Replay with transcript and chapters
Research Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for PVLA:BOATS.
Palvella Therapeutics, Inc. company profile
View the public company page for Palvella Therapeutics, Inc. on 6ix.
Palvella Therapeutics, Inc. news
Read company news and market updates connected to Palvella Therapeutics, Inc..
Palvella Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Palvella Therapeutics, Inc..
Alternate listings
PVLA:NASDAQ
US · USD
Alternate listing for Palvella Therapeutics, Inc.; the primary context on this page is PVLA:BOATS.
PI6:GETTEX
DE · EUR
Alternate listing for Palvella Therapeutics, Inc.; the primary context on this page is PVLA:BOATS.
PI6:FWB
DE · EUR
Alternate listing for Palvella Therapeutics, Inc.; the primary context on this page is PVLA:BOATS.
PI6:MUN
DE · EUR
Alternate listing for Palvella Therapeutics, Inc.; the primary context on this page is PVLA:BOATS.
PI6:TRADEGATE
DE · EUR
Alternate listing for Palvella Therapeutics, Inc.; the primary context on this page is PVLA:BOATS.